Loading…

5174 Predictive factors of response to neoadjuvant 3-weekly epirubicin (EPI) plus docetaxel (DOC) chemotherapy (CT) in locally advanced breast cancer (LABC): a prospective phase II trial

Saved in:

Bibliographic Details
Published in:	European journal of cancer supplements 2009, Vol.7 (2), p.312-312
Main Authors:	Strada, M.R, Frascaroli, M, Palumbo, R, Bernardo, A, Villani, L, Scelsi, M, Jedrychowska, I, Albanese, D, Teragni, C, Bernardo, G
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!